Allergen Alert, a French biotechnology startup supported by bioMérieux, drew global attention by winning Best Startup at the 2026 Consumer Electronics Show (CES), for a device that promises laboratory-grade allergen detection at the table.
The battery-powered unit, reportedly scheduled for release in the second half of 2026 at a retail price of around US$200, is designed to detect gluten and nine major food allergens in prepared meals within minutes. The system automates extraction and analysis using immunoassay‑based technology, on small food samples placed into a patented pouch that is inserted into a handheld device. Results are displayed on the device and a companion app in approximately two minutes, with the company claiming detection sensitivity as low as 4 ppm for gluten and 5 ppm for milk. Each test requires a single-use pouch supplied via a subscription model, and each pouch currently tests for one allergen at a time.
The company positions this not as a replacement for allergen control programs, but as an additional safety option for allergic consumers. Like all immunoassay-based methods, results depend on sampling representativeness and matrix effects, and the presence or absence of an allergen in a small test portion cannot fully eliminate the risk of cross-contact elsewhere in a dish.
Regulators continue to emphasise that food allergen safety rests on preventive controls, validated cleaning, ingredient management and accurate labelling, not end‑point testing alone.
Learn more about Allergen Alert here.
